55
Participants
Start Date
December 31, 2007
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Vorinostat
Vorinostat 200 or 300 mg PO BID on days 1-3 of each weekly paclitaxel dose
Paclitaxel
Paclitaxel 80 mg/m2 weekly for 12 weeks
Trastuzumab
Trastuzumab (if HER2-positive) 4 mg/kg, then 2 mg/kg weekly for 12 weeks including loading dose
Doxorubicin
Doxorubicin 60 mg/m2 every 2 weeks for 8 weeks
Cyclophosphamide
Cyclophosphamide 600 mg/m2 every 2 weeks for 8 weeks
Surgery
Surgical excision of tumor from breast
Montefiore Medical Center, The Bronx
Merck Sharp & Dohme LLC
INDUSTRY
Albert Einstein College of Medicine
OTHER